VA tests smart tool to boost liver cancer screening in veterans
NCT ID NCT06061328
First seen Jan 05, 2026 · Last updated Jun 19, 2026 · Updated 25 times
Summary
This study tests a new decision aid tool that helps VA medical centers pick the best strategies to improve liver cancer screening for veterans with cirrhosis. About 8,020 veterans and clinicians will take part across multiple VA sites. The goal is to see if the tool leads to more patients getting the recommended screening and better health outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Pittsburgh, Pennsylvania, 15240, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
decision aid training (behavioral intervention)
What this could lead to
If successful, this could provide a simple, data-driven tool to help hospitals choose the best strategies for improving care, leading to better liver cancer screening rates.
What could go wrong
This is a behavioral study, not a drug trial. The tool may not improve screening rates more than current methods, and results may not apply outside the VA system.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.